2026 Regular Session
SB124
Food, Drugs, and Cosmetics - Gene Structure- and Function-Modifying Products - Labeling
Earlier-session bill · introduced 2025
Prohibiting a person from offering for sale in the State a gene structure- or function-modifying product unless the product is labeled in a prominent and conspicuous manner with the words "gene structure- or function-modifying product" and all potential risks, side effects, adverse effects, and other reasonably possible effects that the product may have; and establishing penalties for a violation of the Act.
Legislative progress
i
This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.
Committee referrals
January 14, 2026 · Senate
Finance
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
Senate Withdrawn by Sponsor
-
Senate First Reading Finance
-
Senate Pre-filed